Therapeutic potential of mesenchymal stem cells in the treatment of acute liver failure.

Harrell, Carl Randall; Pavlovic, Dragica; Djonov, Valentin; Volarevic, Vladislav (2022). Therapeutic potential of mesenchymal stem cells in the treatment of acute liver failure. World journal of gastroenterology, 28(28), pp. 3627-3636. WJG Press 10.3748/wjg.v28.i28.3627

[img]
Preview
Text
WJG-28-3627.pdf - Published Version
Available under License Creative Commons: Attribution-Noncommercial (CC-BY-NC).

Download (1MB) | Preview

Acute liver failure (ALF) is a severe and life-threatening condition in which rapid deterioration of liver function develops in a patient who has no preexisting liver disease. Mesenchymal stem cells (MSCs) are immunoregulatory stem cells which are able to modulate phenotype and function of all immune cells that play pathogenic role in the development and progression of ALF. MSCs in juxtacrine and paracrine manner attenuate antigen-presenting properties of dendritic cells and macrophages, reduce production of inflammatory cytokines in T lymphocytes, suppress hepatotoxicity of natural killer T (NKT) cells and promote generation and expansion of immunosuppressive T, B and NKT regulatory cells in acutely inflamed liver. Due to their nano-sized dimension and lipid envelope, intravenously injected MSC-derived exosomes (MSC-Exos) may by-pass all biological barriers to deliver MSC-sourced immunoregulatoy factors directly into the liver-infiltrated immune cells and injured hepatocytes. Results obtained by us and others revealed that intravenous administration of MSCs and MSC-Exos efficiently attenuated detrimental immune response and acute inflammation in the liver, suggesting that MSCs and MSC-Exos could be considered as potentially new remedies in the immunotherapy of ALF. In this review, we emphasize the current knowledge about molecular and cellular mechanisms which are responsible for MSC-based modulation of liver-infiltrated immune cells and we discuss different insights regarding the therapeutic potential of MSCs in liver regeneration.

Item Type:

Journal Article (Review Article)

Division/Institute:

04 Faculty of Medicine > Pre-clinic Human Medicine > Institute of Anatomy
04 Faculty of Medicine > Pre-clinic Human Medicine > Institute of Anatomy > Topographical and Clinical Anatomy

UniBE Contributor:

Djonov, Valentin Georgiev

Subjects:

500 Science > 570 Life sciences; biology
600 Technology > 610 Medicine & health

ISSN:

1007-9327

Publisher:

WJG Press

Language:

English

Submitter:

Pubmed Import

Date Deposited:

29 Sep 2022 08:18

Last Modified:

05 Dec 2022 16:25

Publisher DOI:

10.3748/wjg.v28.i28.3627

PubMed ID:

36161038

Uncontrolled Keywords:

Acute liver failure Immunomodulation Mesenchymal stem cells Regeneration Therapy

BORIS DOI:

10.48350/173359

URI:

https://boris.unibe.ch/id/eprint/173359

Actions (login required)

Edit item Edit item
Provide Feedback